Statement Of Cash Flows [Abstract]

Carl Zeiss Meditec AG - Filing #6525304

Concept 2022-10-01 to
2023-09-30
2021-10-01 to
2022-09-30
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Adjustments for decrease (increase) in trade and other receivables
21,178 EUR
74,370 EUR
Adjustments for decrease (increase) in other assets
9,699 EUR
38,273 EUR
Adjustments for increase (decrease) in other liabilities
17,238 EUR
4,762 EUR
Cash flows from (used in) investing activities [abstract]
Proceeds from disposals of property, plant and equipment, intangible assets other than goodwill, investment property and other non-current assets
355,000 EUR
218,000 EUR
Cash flows from (used in) financing activities [abstract]
Dividends paid to equity holders of parent, classified as financing activities
98,385 EUR
80,497 EUR
Dividends paid to non-controlling interests, classified as financing activities
2,194 EUR
3,461 EUR
Cash flows from (used in) increase (decrease) in current borrowings
8,000 EUR
597,000 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.